MetaADEDB 2.0 @ LMMD
Clioquinol
(QCDFBFJGMNKBDO-UHFFFAOYSA-N)
Structure
SMILES
Ic1cc(Cl)c2c(c1O)nccc2
Type(s)
Approved; Vet_approved; Withdrawn
ATC code(s)
D08AH30; D09AA10; G01AC02; P01AA02; P01AA52; S02AA05
Molecular Formula:
C9H5ClINO
Molecular Weight:
305.500
Log P:
3.1984
Hydrogen Bond Acceptor:
2
Hydrogen Bond Donor:
1
TPSA:
33.12
CAS Number(s):
130-26-7; 22112-03-4
Synonym(s)
1.
Clioquinol
2.
Chloroiodoquine
3.
Iodochlorhydroxyquin
4.
Iodochloroxyquinoline
5.
5-Chloro-7-iodo-8-quinolinol
6.
Chinoform
7.
Entero-Septol
8.
Entero-Vioform
9.
Enteroquinol
10.
Vioform
11.
5 Chloro 7 iodo 8 quinolinol
12.
Entero Septol
13.
Entero Vioform
14.
EnteroSeptol
15.
EnteroVioform
External Link(s)
MeSHD007464
PubChem Compound2788
BindingDB32188
ChEBI74460
CHEMBLCHEMBL497
DrugBankDB04815
DrugCentral681
KEGGdr:D03538
Therapeutic Target DatabaseD06ABW
ZINC6409735
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Abdominal PainCanada Vigilance: 1Canada Vigilance
2Acrodermatitis enteropathica230316
6460590		CTD
3Amnesia, Anterograde4106924CTD
4Amnesia, Transient Global160443
2950208
6237545		CTD
5Amnesia6229608CTD
6AngioedemaCanada Vigilance: 1Canada Vigilance
7Anorexia6457437CTD
8AstheniaCanada Vigilance: 1Canada Vigilance
9Ataxia

View details

51051
6091394
6125849
6457437
 		CTD
10Blindness6445513
14759638		CTD
11Brain Diseases

View details

230316
1387790
6229608
6237545
 		CTD
12BronchospasmCanada Vigilance: 1Canada Vigilance
13Cataract14759638CTD
14Colitis76250CTD
15Demyelinating Diseases74637
23360710		CTD
16Depressive disorder19075537CTD
17Dermatitis, Allergic Contact18383004CTD
18DermatitisCanada Vigilance: 1Canada Vigilance
19Diabetes Mellitus, Experimental17434477CTD
20Diarrhea4105685
4258565
22627294		CTD
21Dyspepsia22627294CTD
22Epilepsy, Temporal Lobe2950208CTD
23FlatulenceCanada Vigilance: 1Canada Vigilance
24Gastroenteritis4106924CTD
25Gastrointestinal Diseases4101631CTD
26Hematologic Neoplasms18754030CTD
27HepatomegalyCanada Vigilance: 1Canada Vigilance
28Hyperglycemia17434477CTD
29LaryngospasmCanada Vigilance: 1Canada Vigilance
30Memory Disorders25856695CTD
31Movement Disorders

View details

4143622
4258565
6241266
6457437
14759638
 		CTD
32Muscle Weakness4143622
4258565		CTD
33Nerve Degeneration225920
19679656		CTD
34Optic AtrophyCanada Vigilance: 1

View details

230316
4108984
4112337
4258565
6229608
6460092
 		CTD
Canada Vigilance
35Optic Neuritis

View details

4112337
4283405
4329646
4358276
 		CTD
36PainCanada Vigilance: 14105685CTD
Canada Vigilance
37Paresthesia

View details

4101631
4105685
4108984
4258565
4329646
 		CTD
38Peripheral Nervous System Diseases

View details

230316
4101631
4329646
4358276
6091394
17572442
 		CTD
39Prostatic Neoplasms17308104CTD
40PruritusCanada Vigilance: 1Canada Vigilance
41Reflex, Abnormal74637
225920
6212694		CTD
42Renal Insufficiency4282135CTD
43Seizures4143622CTD
44Spinal Cord Diseases

View details

74637
161413
230316
4358276
6091394
6229608
6460092
17572442
 		CTD
45Spinal Cord Injuries6212694CTD
46Tongue Diseases4118793CTD
47Urinary Incontinence4143622
6445513
14759638		CTD
48Vision Disorders

View details

230316
4108984
4118793
4143622
6241266
6460590
17572442
 		CTD
49VomitingCanada Vigilance: 1Canada Vigilance
50jaundiceCanada Vigilance: 1Canada Vigilance
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120141

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.